Partial peptide of Survivin presented on MHC class II molecule and use thereof

Details for Australian Patent Application No. 2009232774 (hide)

Owner Bioimmulance Co., Ltd.

Inventors Nishimura, Takashi

Agent Pizzeys

Pub. Number AU-A-2009232774

PCT Pub. Number WO2009/123188

Priority 2008-093292 31.03.08 JP

Filing date 31 March 2009

Wipo publication date 8 October 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/123188 Priority application(s): WO2009/123188

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232786-Process for production of reduced iron

2009232768-Method of manufacturing absorptive article and device for manufacturing absorptive article